Clinical Trial Update: The Effect of Synbiotic Consumption on Glycemic, Inflammatory Markers and Body Composition on Prediabetic and Diabetic Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effect of synbiotic consumption on glycemic control, inflammatory markers, and body composition in individuals with predia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes
• Type 2 Diabetes Mellitus

Drugs mentioned

• Synbiotic (probiotic-prebiotic combination)

Snippet

Sponsor: Imam Abdulrahman Bin Faisal University | Conditions: Dietary Supplements | Phase 3 | Status: COMPLETED